Increased histone-DNA complexes and endothelial-dependent thrombin generation in severe COVID-19, 2022, Beth A Bouchard et al

Highlights

The underlying cause(s) of coagulopathy in severe SARS-CoV-2 infection in unknown.

Histones are significantly elevated in the plasma of patients with severe SARS-CoV-2 infection.

Fibrin clots formed in situ are structurally altered in severe COVID-19 infection.

Endothelial cells support thrombin generation in COVID-19 plasma without added tissue factor.

Histone effects on thrombin generation and endothelial cell function may play a role in SARS-CoV-2 coagulopathy.

Abstract

Coagulopathy in severe COVID-19 is common but poorly understood. The purpose of this study was to determine how SARS-CoV-2 infection impacts histone levels, fibrin structure, and endogenous thrombin potential in the presence and absence of endothelial cells. We studied individuals with SARS-CoV-2 infection and acute respiratory distress syndrome at the time of initiation of mechanical ventilation compared to healthy controls. Circulating histone-DNA complexes were elevated in the plasma of COVID-19 patients relative to healthy controls (n=6, each group). Using calibrated automated thrombography, thrombin generation was altered in COVID-19 patient plasma samples. Despite having increased endogenous thrombin potential, patient plasma samples exhibited prolonged lag times and times to peak thrombin in the presence of added tissue factor and PCPS.

Strikingly different results were observed when endothelial cells were used in place of tissue factor and PCPS. While healthy control plasma samples did not generate measurable thrombin after 60 min, plasma samples from COVID-19+ patients formed thrombin (mean lag time ~20 min). Consistent with the observed alterations in thrombin generation, clots from COVID-19 subjects exhibited a denser fibrin network, thinner fibers and lower fibrin resolvability.

Elevated histones, aberrant fibrin formation, and increased endothelial-dependent thrombin generation may contribute to coagulopathy in COVID-19.

https://www.sciencedirect.com/science/article/pii/S1537189121001221